BusinessActinium Pharmaceuticals Highlights Presence at the Society of Hematologic Oncology 2017 Annual MeetingBy Nasdaq OMXSep 13, 2017, 11:30 AM UTC
BusinessActinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common StockBy Nasdaq OMXAug 2, 2017, 8:05 PM UTC
BusinessActinium Announces Proposed Public Offering of Common Stock and Warrants to Purchase StockBy Nasdaq OMXJul 27, 2017, 8:06 PM UTC
BusinessActinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ETBy Nasdaq OMXJul 13, 2017, 11:00 AM UTC
